AI devices with FDA product code QZS — Software-Aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer

Product code QZS (“Software-Aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer” in openFDA) covers 1 device on the FDA AI-enabled list, from 1 company. Most are reviewed by the General and Plastic Surgery panel (1). The most recent decision was DermaSensor on January 12, 2024.